Medicines Co. (MDCO) Posts Narrower-than-Expected Q3 Loss

Medicines Co. (NASDAQ: MDCO) reported Q3 EPS of ($0.64), $0.66 better than the analyst estimate of ($1.30). Revenue for the quarter came in at $37.6 million versus the consensus estimate of $37.26 million.

For earnings history and earnings-related data on Medicines Co. (MDCO) click here.

You May Also Be Interested In

• Tesla to launch Cybercab in Austin this month - report
• L3Harris CEO steps down amid conduct review, shares drop
• Motorsport Games Inc. (MSGM) Tops Q2 EPS by 33c